Characteristics and Outcome of Patients with or without Previous Implantable Cardioverter Defibrillator Interventions Undergoing Ablation for Ventricular Tachycardia

被引:0
|
作者
Bencardino, Gianluigi [1 ]
Narducci, Maria Lucia [1 ]
Scacciavillani, Roberto [1 ,2 ]
Gabrielli, Francesca Augusta [1 ]
Pelargonio, Gemma [1 ,2 ]
Massetti, Massimo [1 ,2 ]
Crea, Filippo [1 ,2 ]
Lanza, Gaetano Antonio [1 ]
机构
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc & Thorac Sci, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Cardiol Inst, I-00136 Rome, Italy
关键词
ventricular arrhythmias; catheter ablation; electrical storm; CATHETER ABLATION;
D O I
10.3390/jcm13164958
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Catheter ablation (CA) is a well-established treatment in patients with ventricular tachycardia and appropriate implantable cardioverter defibrillator (ICD) therapies. Methods: We enrolled 57 consecutive carriers of ICD undergoing CA for electrical storm (ES). Our aim was to investigate differences in clinical, device-related, and electroanatomic features among patients who had history of appropriate ICD interventions before the ES compared to those who had not. The primary endpoint was a composite of death from any cause and recurrences of sustained VT, ventricular fibrillation, appropriate ICD therapy, or ES. Results: During a median follow up of 39 months, 28 patients (49%) met the primary endpoint. Those with previous ICD interventions had a higher prevalence of late potentials and a greater unipolar low-voltage area at electroanatomic mapping. Patients who met the primary endpoint had a higher prevalence of ATP/shock episodes preceding the ES event. At Cox regression analysis, non-ischemic dilated cardiomyopathy (NIDCM), QRS duration, and previous ATP and/or shock before the ES were associated with arrhythmic recurrences and/or death. At multivariate analysis, NIDCM and previous shock were associated with arrhythmic recurrences and/or death. Conclusions: A history of recurrent ICD therapies predicts worse outcomes when CA is needed because of ES. Although more studies are needed to definitively address this question, our data speak in support of an early referral for CA of ES.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Safety of not using the implantable cardioverter-defibrillator in patients with haemodynamically stable sustained ventricular tachycardia
    Lau, EW
    Pathmanathan, RK
    Ng, GA
    Clune, MM
    Cooper, J
    Griffith, MJ
    CIRCULATION, 2000, 102 (18) : 524 - 524
  • [42] Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: Is device implantation justified?
    Russo, AM
    Nayak, H
    Verdino, R
    Springman, J
    Gerstenfeld, E
    Hsia, H
    Marchlinski, FE
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (12): : 2289 - 2295
  • [43] Statin therapy alone reduces risk of ICD shocks in patients with an implantable cardioverter defibrillation undergoing ablation for ventricular tachycardia
    Bunch, T. J.
    Friedman, P. A.
    Gersh, B. J.
    Asirvatham, S. J.
    Brady, P. A.
    Cha, Y. M.
    Jahangir, A.
    Hammill, S. C.
    Monahan, K.
    Munger, T. M.
    Rea, R. F.
    Shen, W. K.
    Tabatabaei, N.
    Packer, D. L.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 : S52 - S52
  • [44] Patient characteristics, predictors and outcome of pacemaker patients upgraded to an implantable cardioverter defibrillator
    Baldinger, Samuel H.
    Burren, Desiree
    Noti, Fabian
    Servatius, Helge
    Seiler, Jens
    Madaffari, Antonio
    Asatryan, Babken
    Tanner, Hildegard
    Reichlin, Tobias
    Haeberlin, Andreas
    Roten, Laurent
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2024, 47 (06): : 853 - 861
  • [45] Anesthetic management of a child with catecholaminergic polymorphic ventricular tachycardia undergoing insertion of implantable cardioverter defibrillator : a case report
    Keisuke Omiya
    Kazuha Mitsui
    Takashi Matsukawa
    JA Clinical Reports, 6
  • [46] Anesthetic management of a child with catecholaminergic polymorphic ventricular tachycardia undergoing insertion of implantable cardioverter defibrillator : a case report
    Omiya, Keisuke
    Mitsui, Kazuha
    Matsukawa, Takashi
    JA CLINICAL REPORTS, 2020, 6 (01)
  • [47] Implantable cardioverter-defibrillator therapy in patients with nonischemic ventricular tachycardia or -fibrillation and normal left ventricular function
    Wichter, T
    Block, M
    MartinezRubio, A
    Brunn, J
    Weber, M
    Bansch, D
    Borggrefe, M
    CIRCULATION, 1996, 94 (08) : 763 - 763
  • [48] IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANTATION IMPROVES OUTCOME OF PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES
    Agrawal, Sahil
    Nanda, Sudip
    Garg, Lohit
    Manda, Yugandhar
    Singh, Amitoj
    Sinha, Archana
    Vefali, Huseng
    Quddus, Abdullah
    Shirani, Jamshid
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1269 - 1269
  • [49] Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade
    Guerra, JM
    Wu, JY
    Miller, JM
    Groh, WJ
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2003, 14 (11) : 1245 - 1247
  • [50] COMBINATION OF ANTITACHYCARDIA PACEMAKER AND AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR FOR VENTRICULAR-TACHYCARDIA
    MANZ, M
    GERCKENS, U
    FUNKE, HD
    KIRCHHOFF, PG
    LUDERITZ, B
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1986, 9 (05): : 676 - 684